- Publish Date: 2014-01-27
Abstract: Atrial fibrillation is the most common arrhythmia affecting patients today. Disease prevalence is increasing at an alarming rate worldwide, and is associated with often catastrophic and costly consequences, including heart failure, syncope, dementia, and stroke. Therapies including anticoagulants, anti-arrhythmic medications, devices, and non-pharmacologic procedures in the last 30 years have improved patients' functionality with the disease. Nonetheless, it remains imperative that further research into AF epidemiology, genetics, detection, and treatments continues to push forward rapidly as the worldwide population ages dramatically over the next 20 years.
|Citation:||Thomas M. Munger, Li-Qun Wu, Win K. Shen. Atrial fibrillation[J]. The Journal of Biomedical Research, 2014, 28(1): 1-17. doi: 10.7555/JBR.28.20130191|